View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML

SSA RIN: 0960-AG74 Publication ID: Fall 2016 
Title: Revised Medical Criteria for Evaluating Cardiovascular Disorders (3477P) 
Abstract:

Sections 4.00 and 104.00, Cardiovascular System, of appendix 1 to subpart P of part 404 of our regulations describe those cardiovascular disorders that we consider severe enough to prevent a person from doing any gainful activity, or that cause marked and severe functional limitations for a child claiming Supplemental Security Income payments under title XVI. We are proposing to revise the criteria in these sections to ensure that the medical evaluation criteria are up-to-date and consistent with the latest advances in medical knowledge and treatment.

 
Agency: Social Security Administration(SSA)  Priority: Other Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Proposed Rule Stage 
Major: No  Unfunded Mandates: No 
EO 13771 Designation: uncollected 
CFR Citation: 20 CFR 404.1500, app 1   
Legal Authority: 42 U.S.C. 402    42 U.S.C. 405(a)    42 U.S.C. 405(b)    42 U.S.C. 405(d) to 405(h)    42 U.S.C. 416(i)    42 U.S.C. 421(a)    42 U.S.C. 421(i)    42 U.S.C. 423    42 U.S.C. 902(a)(5)    42 U.S.C. 1381a    42 U.S.C. 1382c    42 U.S.C. 1383    42 U.S.C. 1383b   
Legal Deadline:  None

Statement of Need:

These rules are required to facilitate disability claims adjudication.

Summary of the Legal Basis:

Sections 4.00 and 104.00, Cardiovascular System, of appendix 1 to subpart P of part 404 of our regulations.

This proposed rule is not required by statute or court order.

Alternatives:

We considered continuing to use our current criteria. However, we believe these proposed revisions are necessary because of medical advances since we last published our final rule

Anticipated Costs and Benefits:

Ensuring that the medical evaluation criteria are up-to-date and consistent with the latest advances in medical knowledge, technology, and treatment will provide for accurate disability evaluations.

Costs: While no cost is expected, documentation is not yet available.

Risks:

Timetable:
Action Date FR Cite
ANPRM  04/16/2008  73 FR 20564   
ANPRM Comment Period End  06/16/2008    
NPRM  07/00/2017 
Additional Information: Includes Retrospective Review under E.O. 13563.
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: No  Federalism: No 
Included in the Regulatory Plan: Yes 
Public Comment URL: www.regulations.gov  
RIN Data Printed in the FR: No 
Agency Contact:
Cheryl A. Williams
Director
Social Security Administration
Office of Medical Policy, 6401 Security Boulevard,
Baltimore, MD 21235-6401
Phone:410 965-1020
Email: cheryl.a.williams@ssa.gov